EP2928470A4 - Thienopyridinderivate zur behandlung und vorbeugung von dengue-virusinfektionen - Google Patents
Thienopyridinderivate zur behandlung und vorbeugung von dengue-virusinfektionenInfo
- Publication number
- EP2928470A4 EP2928470A4 EP13859644.0A EP13859644A EP2928470A4 EP 2928470 A4 EP2928470 A4 EP 2928470A4 EP 13859644 A EP13859644 A EP 13859644A EP 2928470 A4 EP2928470 A4 EP 2928470A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prevention
- treatment
- dengue virus
- virus infections
- thienopyridine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/708,224 US20130129677A1 (en) | 2009-02-27 | 2012-12-07 | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
PCT/US2013/073449 WO2014089378A1 (en) | 2012-12-07 | 2013-12-06 | Thienopyridine derivatives for the treatment and prevention of dengue virus infections |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2928470A1 EP2928470A1 (de) | 2015-10-14 |
EP2928470A4 true EP2928470A4 (de) | 2015-12-16 |
Family
ID=50884015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13859644.0A Withdrawn EP2928470A4 (de) | 2012-12-07 | 2013-12-06 | Thienopyridinderivate zur behandlung und vorbeugung von dengue-virusinfektionen |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2928470A4 (de) |
JP (1) | JP2016501883A (de) |
CA (1) | CA2893318A1 (de) |
WO (1) | WO2014089378A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105418635A (zh) * | 2015-12-25 | 2016-03-23 | 上海应用技术学院 | 一种噻吩并吡啶类医药中间体的合成方法 |
CN105832734B (zh) * | 2016-03-31 | 2018-05-04 | 南通江海港建设工程有限公司 | 一种化合物在增加血小板浓度药物中的用途 |
CN105769866B (zh) * | 2016-03-31 | 2018-05-04 | 南通江海港建设工程有限公司 | 一种化合物在增加血小板浓度药物中的用途 |
US10689394B2 (en) | 2016-06-14 | 2020-06-23 | The University Of Tokyo | Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereof |
JP7499698B2 (ja) | 2017-11-03 | 2024-06-14 | ウニヴェルシテ ド モントリオール | 化合物及び幹細胞及び/又は前駆細胞の増殖におけるその使用 |
JP7445609B2 (ja) * | 2018-06-06 | 2024-03-07 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Epac阻害剤としてのチエノ[2,3-b]ピリジン誘導体及びその医薬用途 |
CN115003383B (zh) * | 2019-08-21 | 2024-10-01 | 斯克里普斯研究学院 | 干扰素基因刺激物sting的双环激动剂 |
CN111072463A (zh) * | 2019-12-03 | 2020-04-28 | 辽宁凯莱英医药化学有限公司 | 一种4-乙氧基-1,1,1-三氟-3-丁烯-2-酮的连续化合成方法 |
WO2021108999A1 (zh) * | 2019-12-03 | 2021-06-10 | 辽宁凯莱英医药化学有限公司 | 一种4-乙氧基-1,1,1-三氟-3-丁烯-2-酮的连续化合成方法 |
EP4164637A1 (de) * | 2020-06-12 | 2023-04-19 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Thienopyridinderivate zur verwendung bei der behandlung von coronavirusinfektionen |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020151544A1 (en) * | 2000-04-27 | 2002-10-17 | Masahiko Hayakawa | Fused heteroaryl derivatives |
WO2006068618A1 (en) * | 2004-12-23 | 2006-06-29 | Astrazeneca Ab | New compounds |
JP2006298909A (ja) * | 2005-03-25 | 2006-11-02 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
WO2007136776A2 (en) * | 2006-05-17 | 2007-11-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pyrimidine low molecular weight ligands for modulating hormone receptors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996009296A1 (fr) * | 1994-09-22 | 1996-03-28 | Rational Drug Design Laboratories | Derive d'arylthiadiazole et agent antiviral le contenant |
GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
US7202363B2 (en) * | 2003-07-24 | 2007-04-10 | Abbott Laboratories | Thienopyridine and furopyridine kinase inhibitors |
AR048669A1 (es) * | 2004-03-03 | 2006-05-17 | Syngenta Ltd | Derivados biciclicos de bisamida |
KR20110136819A (ko) * | 2009-02-27 | 2011-12-21 | 시가 테크놀로지스, 인크. | 뎅기 바이러스 감염의 치료 및 예방을 위한 티에노피리딘 유도체 |
US20130129677A1 (en) * | 2009-02-27 | 2013-05-23 | Siga Technologies, Inc. | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
WO2011006158A2 (en) * | 2009-07-10 | 2011-01-13 | University Of Maryland, Baltimore | Targeting nad biosynthesis in bacterial pathogens |
-
2013
- 2013-12-06 EP EP13859644.0A patent/EP2928470A4/de not_active Withdrawn
- 2013-12-06 CA CA2893318A patent/CA2893318A1/en not_active Abandoned
- 2013-12-06 WO PCT/US2013/073449 patent/WO2014089378A1/en active Application Filing
- 2013-12-06 JP JP2015545858A patent/JP2016501883A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020151544A1 (en) * | 2000-04-27 | 2002-10-17 | Masahiko Hayakawa | Fused heteroaryl derivatives |
WO2006068618A1 (en) * | 2004-12-23 | 2006-06-29 | Astrazeneca Ab | New compounds |
JP2006298909A (ja) * | 2005-03-25 | 2006-11-02 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
WO2007136776A2 (en) * | 2006-05-17 | 2007-11-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pyrimidine low molecular weight ligands for modulating hormone receptors |
Non-Patent Citations (1)
Title |
---|
See also references of WO2014089378A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2893318A1 (en) | 2014-06-12 |
JP2016501883A (ja) | 2016-01-21 |
WO2014089378A1 (en) | 2014-06-12 |
EP2928470A1 (de) | 2015-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201500921B (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases | |
IL244431A0 (en) | Pharmacy methods and preparations for the treatment of hepatitis b virus infection | |
EP2400845A4 (de) | Thienopyridinderivate zur behandlung und vorbeugung von dengue-virusinfektionen | |
ZA201405820B (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
HK1210463A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
HK1203944A1 (zh) | 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類 | |
HK1222398A1 (zh) | 治療伯克霍爾德氏菌感染症的組合物及方法 | |
EP2928470A4 (de) | Thienopyridinderivate zur behandlung und vorbeugung von dengue-virusinfektionen | |
IL236221A (en) | History of theophyridone and pharmacological preparations containing them for the treatment of diseases | |
HK1210022A1 (en) | Methods for the treatment of hepatitis b and hepatitis d infections | |
HUE044216T2 (hu) | Kitin vagy annak származékai parazitózisok megelõzésére és/vagy kezelésére | |
HK1211221A1 (en) | Formulations for the treatment and prevention of obesity | |
PL3082845T3 (pl) | Sposoby i kompozycje do leczenia neuropatii obwodowych | |
HK1201181A1 (en) | Novel cyclosporin derivatives for the treatment and prevention of viral infections | |
HK1206594A1 (en) | Materials and methods for prevention and treatment of viral infections | |
HK1205680A1 (en) | Agent for the treatment of hepatitis c virus | |
AP2015008726A0 (en) | Low-glycerin-formulations for hiv treatment and prevention | |
ZA201407866B (en) | Composition for the prevention and treatment of viral infections caused by retroviruses | |
AU2012905097A0 (en) | Agents and methods for inhibiting virus infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150701 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BYRD, CHELSEA, M. Inventor name: BURGESON, JAMES, R. Inventor name: HRUBY, DENNIS, E. Inventor name: DAI, DONGCHENG Inventor name: TYAVANAGIMATT, SHANTHAKUMAR, R. |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20151113 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/4365 20060101AFI20151109BHEP Ipc: A61K 31/4375 20060101ALI20151109BHEP Ipc: C07D 495/14 20060101ALI20151109BHEP Ipc: C07D 495/06 20060101ALI20151109BHEP Ipc: C07D 495/22 20060101ALI20151109BHEP |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TYAVANAGIMATT, SHANTHAKUMAR, R. Inventor name: BURGESON, JAMES, R. Inventor name: HRUBY, DENNIS, E. Inventor name: BYRD, CHELSEA, M. Inventor name: DAI, DONGCHENG |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20170713 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20171124 |